{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:30:15Z","timestamp":1791891015715,"version":"4.3.4"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Porphyria cutanea tarda (PCT), the commonest of all porphyrias, is usually characterized by blisters and fragility of skin in light-exposed areas. It can be clinically indistinguishable from other disorders including variegate porphyria and the diagnosis can only be made by rigorous biochemical analysis. PCT does not cause acute attacks of porphyria. It is usually an acquired condition caused by inhibition of the uroporphyrinogen decarboxylase enzyme in the liver. Hereditary haemochromatosis, hepatitis C virus infection, alcohol, oestrogens and a family history of PCT are the major risk factors for the condition and should be searched for specifically in all patients. Liver disease, including hepatocellular carcinoma, is common in patients with PCT, and should be investigated for at presentation by means of a liver biopsy where possible. Patients with severe hepatic pathology or longstanding untreated PCT need to be monitored for the development of hepatocellular carcinoma in the long term. Low dose twice weekly chloroquine is the mainstay of treatment, but venesection should be used in patients with severe iron overload or hepatitis C-related liver disease. Subsequently, long-term follow-up is needed in all patients to monitor for relapse.<\/jats:p>","DOI":"10.1046\/j.1365-2230.2001.00825.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:03:28Z","timestamp":1047377008000},"page":"225-232","source":"Crossref","is-referenced-by-count":91,"title":["The management of porphyria cutanea tarda"],"prefix":"10.1093","volume":"26","author":[{"given":"R. P. E.","family":"Sarkany","sequence":"first","affiliation":[{"name":"Photobiology Department, St. John's Institute of Dermatology, St Thomas's Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2001,5,1]]},"reference":[{"key":"2023013105374528700_b1","first-page":"67","author":"Dean","year":"1971:","edition":"2nd edn"},{"key":"2023013105374528700_b2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-2007-1007142","article-title":"Porphyria cutanea tarda","volume":"18","author":"Elder","year":"1998","journal-title":"Semin Liver Dis"},{"issue":"Suppl.","key":"2023013105374528700_b3","first-page":"1","article-title":"Studien \u00fcber Porphyrie","volume":"82","author":"Waldenstrom","year":"1937","journal-title":"Acta Med Scand"},{"key":"2023013105374528700_b4","first-page":"476","article-title":"Untersuchungen \u00fcber die biologische (photodynamische) Wirkung des H\u00e4matoporphyrins und anderer Derivate des Blut- und Gallenfarbstoffs","volume":"112","author":"Meyer-Betz","year":"1913","journal-title":"Deutsch Arch Klin Med"},{"key":"2023013105374528700_b5","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1172\/JCI111616","article-title":"Activation of the complement system in patients with porphyrias after irradiation in vivo","volume":"74","author":"Lim","year":"1984","journal-title":"J Clin Invest"},{"key":"2023013105374528700_b6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0002-9343(79)90403-0","article-title":"Porphyria cutanea tarda: clinical features and laboratory findings in 40 patients","volume":"67","author":"Grossman","year":"1979","journal-title":"Am J Med"},{"issue":"Suppl.","key":"2023013105374528700_b7","first-page":"17","article-title":"Microscopic and fine structural aspects of porphyrias","volume":"100","author":"Wolff","year":"1982","journal-title":"Acta Dermatovenereol (Stockh)"},{"key":"2023013105374528700_b8","first-page":"115","article-title":"Uroporphyrinogen-decarboxylase deficiencies: porphyria cutanea tarda and related conditions","volume":"5","author":"Mascaro","year":"1986","journal-title":"Semin Dermatol"},{"key":"2023013105374528700_b9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1440-0960.1983.tb00266.x","article-title":"Porphyria and scleroderma: a clinical and laboratory review of 12 patients","volume":"24","author":"Doyle","year":"1983","journal-title":"Australas J Dermatol"},{"key":"2023013105374528700_b10","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/pgmj.52.610.535","article-title":"Contraceptive pill-induced porphyria cutanea tarda presenting with onycholysis of the finger nails","volume":"52","author":"Byrne","year":"1976","journal-title":"Postgrad Med J"},{"key":"2023013105374528700_b11","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000246284","article-title":"Hepatoerythropoietic porphyria: relationship with familial porphyria cutanea tarda","volume":"193","author":"Castano Suarez","year":"1996","journal-title":"Dermatology"},{"key":"2023013105374528700_b12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(85)90287-9","article-title":"Immunoreactive uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda","volume":"2","author":"Elder","year":"1985","journal-title":"Lancet"},{"key":"2023013105374528700_b13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archderm.1964.01590300021006","article-title":"Industrially acquired porphyria","volume":"89","author":"Bleiberg","year":"1964","journal-title":"Arch Dermatol"},{"key":"2023013105374528700_b14","first-page":"405","article-title":"Uroporphyrinogen decarboxylase and protoporphyrinogen oxidase in dual porphyria","volume":"76","author":"Sturrock","year":"1989","journal-title":"S Afr Med J"},{"key":"2023013105374528700_b15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-8981(94)90097-3","article-title":"Rapid and accurate random urinary porphyrin quantitation","volume":"226","author":"Boynton","year":"1994","journal-title":"Clin Chim Acta"},{"key":"2023013105374528700_b16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0738-081X(99)00029-2","article-title":"Alcohol intake and porphyria cutanea tarda","volume":"17","author":"Elder","year":"1999","journal-title":"Clin Dermatol"},{"key":"2023013105374528700_b17","first-page":"178","article-title":"Liver involvement in porphyria","volume":"5","author":"Bruguera","year":"1986","journal-title":"Semin Dermatol"},{"key":"2023013105374528700_b18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0168-8278(95)80108-1","article-title":"Iron storage, lipid peroxidation and glutathione turnover in chronic HCV-positive hepatitis","volume":"22","author":"Farinati","year":"1995","journal-title":"J Hepatol"},{"key":"2023013105374528700_b19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1440-1746.1999.01836.x","article-title":"Interrelationships of alcohol and iron in liver disease with particular reference to the iron-binding proteins, ferritin and transferrin","volume":"14","author":"Fletcher","year":"1999","journal-title":"Gastroenterol Hepatol"},{"key":"2023013105374528700_b20","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood.V95.5.1565.005k42_1565_1571","article-title":"Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda","volume":"95","author":"Bulaj","year":"2000","journal-title":"Blood"},{"key":"2023013105374528700_b21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(96)09436-6","article-title":"Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda","volume":"349","author":"Roberts","year":"1997","journal-title":"Lancet"},{"key":"2023013105374528700_b22","first-page":"248","article-title":"Iron overload in porphyria cutanea tarda","volume":"84","author":"Sampietro","year":"1999","journal-title":"Haematologica"},{"key":"2023013105374528700_b23","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/j.1530-0277.1996.tb01134.x","article-title":"Alcohol mediates increases in hepatic and serum nonheme iron stores in a rat model for alcohol-induced liver injury","volume":"20","author":"Valerio","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"2023013105374528700_b24","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/hep.1840160603","article-title":"Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association","volume":"16","author":"Fargion","year":"1992","journal-title":"Hepatology"},{"key":"2023013105374528700_b25","first-page":"321","article-title":"Role of hepatitis C virus in porphyria cutanea tarda hepatopathy","volume":"106","author":"Quecedo","year":"1996","journal-title":"Med Clin (Barc)"},{"key":"2023013105374528700_b26","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/hep.1840210604","article-title":"Low prevalence of hepatitis C virus infection in porphyria cutanea tarda in Germany","volume":"21","author":"Stolzel","year":"1995","journal-title":"Hepatology"},{"key":"2023013105374528700_b27","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/0140-6736(93)90670-C","article-title":"HCV infection in porphyria cutanea tarda","volume":"341","author":"Murphy","year":"1993","journal-title":"Lancet"},{"key":"2023013105374528700_b28","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/archderm.1997.03890450044005","article-title":"Screening of patients with iron overload to identify haemochromatosis and porphyria cutanea tarda","volume":"133","author":"O'Reilly","year":"1997","journal-title":"Arch Dermatol"},{"key":"2023013105374528700_b29","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/archderm.1996.03890360034007","article-title":"Abnormal urinary coproporphyrin levels in patients infected by Hepatitis C virus with or without human immunodeficiency virus: a study of 177 patients","volume":"132","author":"Cribier","year":"1996","journal-title":"Arch Dermatol"},{"key":"2023013105374528700_b30","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1001\/jama.1951.03670130029009","article-title":"Adult form of chronic porphyria with cutaneous manifestations","volume":"146","author":"Brunsting","year":"1951","journal-title":"J Am Med Assoc"},{"key":"2023013105374528700_b31","first-page":"653","article-title":"Porphyria cutanea tarda: comparison of cases precipitated by alcohol and estrogens","volume":"113","author":"Haberman","year":"1975","journal-title":"Can Med Assoc J"},{"key":"2023013105374528700_b32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0190-9622(08)82010-5","article-title":"Treatment of porphyria cutanea tarda of end-stage renal disease with erythropoietin","volume":"29","author":"Sarkell","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"2023013105374528700_b33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1365-4362.1992.tb02693.x","article-title":"Porphyria cutanea tarda and human immunodeficiency virus infection","volume":"31","author":"Blauvelt","year":"1992","journal-title":"Int J Dermatol"},{"key":"2023013105374528700_b34","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archderm.1996.03890360029006","article-title":"Porphyrin abnormalities in acquired immunodeficiency syndrome","volume":"132","author":"O'Connor","year":"1996","journal-title":"Arch Dermatol"},{"key":"2023013105374528700_b35","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/archderm.1973.01620270005001","article-title":"Lupus erythematosus and porphyria","volume":"108","author":"Cram","year":"1973","journal-title":"Arch Dermatol"},{"key":"2023013105374528700_b36","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/carcin\/6.4.631","article-title":"Hepatocarcinogenicity of hexachlorobenzene in rats and the sex difference in hepatic iron status and development of porphyria","volume":"6","author":"Smith","year":"1985","journal-title":"Carcinogenesis"},{"key":"2023013105374528700_b37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-0676.1992.tb00557.x","article-title":"Hepatocellular carcinoma in porphyria cutanea tarda: frequency and factors related to its occurrence","volume":"12","author":"Siersema","year":"1992","journal-title":"Liver"},{"key":"2023013105374528700_b38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0168-8278(85)80746-7","article-title":"Porphyria cutanea tarda and hepatocellular carcinoma. Frequency of occurrence and related factors","volume":"1","author":"Salata","year":"1985","journal-title":"J Hepatol"},{"key":"2023013105374528700_b39","first-page":"517","article-title":"Acquired porphyria from a liver tumor","volume":"16","author":"Tio","year":"1957","journal-title":"Clin Sci"},{"key":"2023013105374528700_b40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1023\/A:1018854906444","article-title":"Dramatic resolution of skin lesions associated with porphyria cutanea tarda after interferon-alpha therapy in a case of chronic hepatitis C","volume":"43","author":"Sheikh","year":"1998","journal-title":"Dig Dis Sci"},{"issue":"Suppl.","key":"2023013105374528700_b41","first-page":"119","article-title":"Chloroquine in treatment of porphyria cutanea tarda: long-term efficacy of combined phlebotomy and high-dose chloroquine therapy","volume":"100","author":"Wennersten","year":"1982","journal-title":"Acta Dermatovener (Stockh)"},{"key":"2023013105374528700_b42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1440-0960.1988.tb01216.x","article-title":"Plasma ferritin levels as a guide to the treatment of porphyria cutanea tarda by venesection","volume":"29","author":"Ratnaike","year":"1988","journal-title":"Australas J Dermatol"},{"key":"2023013105374528700_b43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1440-0960.1983.tb00266.x","article-title":"Porphyria and scleroderma: a clinical and laboratory review of 12 patients","volume":"24","author":"Doyle","year":"1983","journal-title":"Australas J Dermatol"},{"key":"2023013105374528700_b44","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2340\/0001555561346350","article-title":"A comparative study of the results of phlebotomy therapy and low-dose chloroquine treatment in porphyria cutanea tarda","volume":"61","author":"Malina","year":"1981","journal-title":"Acta Dermatovenereol (Stockh)"},{"key":"2023013105374528700_b45","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2133.1986.tb04071.x","article-title":"Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion","volume":"114","author":"Rocchi","year":"1986","journal-title":"Br J Dermatol"},{"key":"2023013105374528700_b46","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/archderm.1957.01550180015004","article-title":"Porphyria cutanea tarda: report of a case successfully treated with chloroquine","volume":"57","author":"London","year":"1957","journal-title":"Arch Dermatol"},{"key":"2023013105374528700_b47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/archderm.100.3.375","article-title":"Porphyria cutanea tarda treated with chloroquine phosphate","volume":"100","author":"Bloom","year":"1969","journal-title":"Arch Dermatol"},{"key":"2023013105374528700_b48","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.1984.tb06632.x","article-title":"Low-dose oral chloroquine in the treatment of porphyria cutanea tarda","volume":"111","author":"Ashton","year":"1984","journal-title":"Br J Dermatol"},{"key":"2023013105374528700_b49","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0923-1811(94)90092-2","article-title":"Low-dose oral chloroquine in patients with porphyria cutanea tarda and low\u2013moderate iron overload","volume":"7","author":"Valls","year":"1994","journal-title":"J Dermatol Sci"},{"key":"2023013105374528700_b50","first-page":"16","article-title":"Agents affecting porphyrin formation and secretion: implications for porphyria cutanea tarda treatment","volume":"26","author":"Kordac","year":"1989","journal-title":"Semin Hematol"},{"key":"2023013105374528700_b51","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2133.1983.tb01062.x","article-title":"Hydroxychloroquine versus phlebotomy in the treatment of porphyria cutanea tarda","volume":"108","author":"Cainelli","year":"1983","journal-title":"Br J Dermatol"},{"key":"2023013105374528700_b52","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/archderm.1980.01640340057016","article-title":"Hydroxychloroquine treament of porphyria cutanea tarda","volume":"116","author":"Malkinson","year":"1980","journal-title":"Arch Dermatol"},{"key":"2023013105374528700_b53","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/1523-1747.ep12676478","article-title":"The molecular basis of the action of chloroquine in porphyria cutanea tarda","volume":"61","author":"Scholnick","year":"1973","journal-title":"J Invest Dermatol"},{"key":"2023013105374528700_b54","first-page":"163","article-title":"Commentary: iron metabolism in Hepatitis C infection","volume":"30","author":"Roeckel","year":"2000","journal-title":"Ann Clin Lab Sci"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2230.2001.00825.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2230.2001.00825.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/26\/3\/225\/48958032\/ced0225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/26\/3\/225\/48958032\/ced0225.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T00:02:40Z","timestamp":1682121760000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/26\/3\/225\/6628007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5,1]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2001,5,1]]},"published-print":{"date-parts":[[2001,5,1]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2230.2001.00825.x","relation":{},"ISSN":["1365-2230","0307-6938"],"issn-type":[{"value":"1365-2230","type":"electronic"},{"value":"0307-6938","type":"print"}],"subject":[],"published-other":{"date-parts":[[2001,5,1]]},"published":{"date-parts":[[2001,5,1]]}}}